TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15342049

Group type: EXPERIMENTAL
Intervention: Sharp-edged acrylic IOL (Sensar OptiEdge AR40e)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Round-edged acrylic IOL (AR40)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Sharp-edged silicone IOL (ClariFlex OptiEdge)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Round-edged silicone IOL (PhacoFlex SI-40)
Number of subjects: 105
Study: 11583720

Group type: EXPERIMENTAL
Intervention: colesevelam 3.8 g/day
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: atorvastatin 10 mg/day
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: coadministered colesevelam 3.8 g/day plus atorvastatin 10 mg/day
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: atorvastatin 80 mg/day
Number of subjects: 94

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 94
Study: 9641933

Group type: EXPERIMENTAL
Intervention: Educational intervention with summary leaflet
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Educational intervention with Family Planning Association's leaflet
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Asking questions
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Asking questions in addition to summary leaflet
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Asking questions in addition to Family Planning Association leaflet
Number of subjects: 636

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 636
Study: 8018463

Group type: EXPERIMENTAL
Intervention: Nadroparin (0.4 ml)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enoxaparin (0.4 ml)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 12
Study: 2680995

Group type: EXPERIMENTAL
Intervention: L-lactate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bicarbonate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acetate
Number of subjects: 0
Study: 1187953

Group type: EXPERIMENTAL
Intervention: N-desmethyldiazepam
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 6

Group type: COMPARATOR
Intervention: N-desmethyldiazepam and Diazepam
Number of subjects: 6
Study: 30770436

Group type: EXPERIMENTAL
Intervention: Real-time feedback and brief coaching
Number of subjects: 298

Group type: COMPARATOR
Intervention: Measurement-only (control)
Number of subjects: 298
Study: 31865604

Group type: EXPERIMENTAL
Intervention: 3 fractions of 4-6 Gy per fraction (3 fractions/week)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: 2 consecutive daily fractions of 5-6 Gy
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Single fraction of 7 Gy
Number of subjects: 325

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 325
Study: 29759512

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 599
Study: 27059039

Group type: EXPERIMENTAL
Intervention: Water Exchange (WE)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Air Insufflation (AI)
Number of subjects: 403
Study: 24920349

Group type: EXPERIMENTAL
Intervention: Levosimendan (0.2 µg/kg/min) administered for 6 h at 2-week intervals over 6 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo administered for 6 h at 2-week intervals over 6 weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: COMPARATOR
Intervention: Levosimendan and Placebo
Number of subjects: 120
Study: 22746016

Group type: EXPERIMENTAL
Intervention: L group (Landiolol)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: LO group (Landiolol + Olprinone)
Number of subjects: 24
Study: 20097585

Group type: EXPERIMENTAL
Intervention: Foam sclerotherapy with compression stockings (15-20 mmHg worn during the day, for 3 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Foam sclerotherapy without compression
Number of subjects: 60
Study: 17945300

Group type: EXPERIMENTAL
Intervention: Botulinum-A toxin alone
Number of subjects: 23

Group type: COMPARATOR
Intervention: Botulinum-A toxin with oxybutynin chloride (control group)
Number of subjects: 23
Study: 16222918

Group type: EXPERIMENTAL
Intervention: Prenatal multiple micronutrient supplements (MM), 6 days per week from early pregnancy to delivery.
Number of subjects: 570

Group type: COMPARATOR
Intervention: Iron only (FE) supplements, 6 days per week from early pregnancy to delivery.
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Prenatal multiple micronutrient supplements (MM) among overweight women.
Number of subjects: 570

Group type: COMPARATOR
Intervention: Iron only (FE) supplements among non-overweight women.
Number of subjects: 570
Study: 12010137

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 236

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 236

Group type: COMPARATOR
Intervention: Cyclosporin
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Diabetic patients with opportunistic infections
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Age of patients with complications
Number of subjects: 236
Study: 10510142

Group type: EXPERIMENTAL
Intervention: Chlorpromazine 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Risperidone 2 mg
Number of subjects: 12
Study: 8595789

Group type: EXPERIMENTAL
Intervention: Tiagabine (TGB) hydrochloride monotherapy
Number of subjects: 144

Group type: COMPARATOR
Intervention: Tiagabine (TGB) hydrochloride monotherapy (high-dose)
Number of subjects: 144
Study: 1720407

Group type: EXPERIMENTAL
Intervention: Preinduction regimen with low-dose methotrexate followed by CHOP-Bleo chemotherapy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional chemotherapy with CHOP-Bleo
Number of subjects: 98
Study: 6784581

Group type: COMPARATOR
Intervention: Atropine 3 micrograms/kg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Atropine 6 micrograms/kg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Atropine 12 micrograms/kg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Atropine 24 micrograms/kg
Number of subjects: 5

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 5
Study: 31408870

Group type: EXPERIMENTAL
Intervention: Music therapy (Sufi music at low tempo)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (no music therapy)
Number of subjects: 70
Study: 28578819

Group type: EXPERIMENTAL
Intervention: Home-based dexterity program (HOMEDEXT)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Thera-band program
Number of subjects: 103
Study: 25539931

Group type: EXPERIMENTAL
Intervention: Midluteal (ML) phase after total sleep deprivation (TSD)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Early follicular (EF) phase after total sleep deprivation (TSD)
Number of subjects: 14
Study: 24166760

Group type: COMPARATOR
Intervention: MC4‐NN2‐0453 (0.03-1.50 mg/kg single dose)
Number of subjects: 136

Group type: COMPARATOR
Intervention: MC4‐NN2‐0453 (0.75-3.0 mg/day multiple doses)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 22485050

Group type: EXPERIMENTAL
Intervention: ACWY‐TT
Number of subjects: 1247

Group type: COMPARATOR
Intervention: MenPS
Number of subjects: 1247
Study: 19919594

Group type: COMPARATOR
Intervention: Brief intervention only (single 90-minute session)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: 10 sessions with alcohol focus
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: 10 sessions with depression focus
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: 10 sessions with integrated focus
Number of subjects: 284
Study: 17853761

Group type: EXPERIMENTAL
Intervention: Xingnao Kaiqiao needling method
Number of subjects: 4377

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4377
Study: 15761214

Group type: EXPERIMENTAL
Intervention: Modified milk fat (ModFat)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Regular milk fat (RegFat)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Soft margarine (Marg)
Number of subjects: 31
Study: 12140141

Group type: EXPERIMENTAL
Intervention: Vinorelbine 25 mg/m² intravenous bolus on days 1 and 8 plus cisplatin 100 mg/m² on day 1 every 4 weeks (VC)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Mitomycin C 8 mg/m² i.v. on day 1, vindesine 3 mg/m² i.v. on days 1, 8, 15 and 22, plus cisplatin 100 mg/m² on day 1 every 4 weeks (MVP)
Number of subjects: 247

Group type: COMPARATOR
Intervention: MVP regimen
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: VC regimen
Number of subjects: 247
Study: 9698962

Group type: EXPERIMENTAL
Intervention: Trach‐Vent heat and moisture exchanger
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Aerodyne humidifier
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nam 35 humidifier
Number of subjects: 10
Study: 7796569

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 600 mg for 1 year
Number of subjects: 18

Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 18
Study: 2082305

Group type: EXPERIMENTAL
Intervention: ketorolac tromethamine 10 mg 4 times a day as needed
Number of subjects: 823

Group type: COMPARATOR
Intervention: aspirin 650 mg 4 times a day as needed
Number of subjects: 823
Study: 7264966

Group type: EXPERIMENTAL
Intervention: Pre-existing activity and spinal stretch reflex during falls
Number of subjects: 0
Study: 30794568

Group type: EXPERIMENTAL
Intervention: 20 min of 1.98 mA anodal tDCS applied over the primary motor cortex (M1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham-operated control
Number of subjects: 10
Study: 28045335

Group type: EXPERIMENTAL
Intervention: Capecitabine plus erlotinib (Arm 2)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Capecitabine alone (Arm 1)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Capecitabine plus erlotinib (Arm 2) in KRAS-WT patients
Number of subjects: 82

Group type: COMPARATOR
Intervention: Capecitabine alone (Arm 1) in KRAS-WT patients
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Capecitabine plus erlotinib (Arm 2) in KRAS-mutated patients
Number of subjects: 82

Group type: COMPARATOR
Intervention: Capecitabine alone (Arm 1) in KRAS-mutated patients
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Capecitabine plus erlotinib (Arm 2) in left-sided KRAS-WT patients
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Capecitabine plus erlotinib (Arm 2) in right-sided KRAS-WT patients
Number of subjects: 82
Study: 25448095

Group type: EXPERIMENTAL
Intervention: Provider-focused intervention (repeated contacts, education, individualized feedback, quality improvement incentives)
Number of subjects: 4093

Group type: EXPERIMENTAL
Intervention: Provider-focused intervention
Number of subjects: 4093
Study: 23415550

Group type: EXPERIMENTAL
Intervention: Operative fixation of fractured ribs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current best practice mechanical ventilator management (control group)
Number of subjects: 0
Study: 17473118

Group type: EXPERIMENTAL
Intervention: Single doses of ACP-103 (20-300 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple doses of ACP-103 (50-150 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single doses of ACP-103 (up to 300 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple doses of ACP-103 (up to 100 mg once daily for 14 days)
Number of subjects: 0
Study: 14769702

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg/d
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 10935954

Group type: EXPERIMENTAL
Intervention: Class II elastics (Begg technique)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Fixed functional appliances (Herbst appliance)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 8937662

Group type: EXPERIMENTAL
Intervention: On-demand system supplying compressed air from high pressure cylinders using a demand valve
Number of subjects: 9

Group type: COMPARATOR
Intervention: Ambient room air (control)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: On-demand system supplying compressed air
Number of subjects: 9
Study: 8237845

Group type: EXPERIMENTAL
Intervention: Formula supplemented with taurine (479 mumol/L)
Number of subjects: 30
Study: 3768270

Group type: EXPERIMENTAL
Intervention: Therapists who made accurate predictions of patient behavior
Number of subjects: 0

Group type: COMPARATOR
Intervention: Therapists who made reflections or requested further information
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapists who employed accurate predictions
Number of subjects: 0
Study: 31666076

Group type: EXPERIMENTAL
Intervention: Revefenacin 175 μg
Number of subjects: 1055

Group type: EXPERIMENTAL
Intervention: Revefenacin 88 μg
Number of subjects: 1055

Group type: COMPARATOR
Intervention: Tiotropium (active control)
Number of subjects: 1055

Group type: EXPERIMENTAL
Intervention: All treatment arms (including Revefenacin and Tiotropium)
Number of subjects: 1055
Study: 28259621

Group type: EXPERIMENTAL
Intervention: Power Through Choices (PTC) intervention
Number of subjects: 1036
Study: 26386635

Group type: EXPERIMENTAL
Intervention: Training of health care providers using the '20‐Hour Course For Maternity Staff'
Number of subjects: 422

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 422
Study: 22850475

Group type: EXPERIMENTAL
Intervention: Attention bias scores for children with no diagnosis (n = 1411)
Number of subjects: 1774

Group type: EXPERIMENTAL
Intervention: Attention bias scores for children with distress-related disorders (n = 66)
Number of subjects: 1774

Group type: EXPERIMENTAL
Intervention: Attention bias scores for children with fear-related disorders (n = 86)
Number of subjects: 1774

Group type: COMPARATOR
Intervention: Attention bias scores for children with behavior disorders (n = 211)
Number of subjects: 1774
Study: 22077985

Group type: EXPERIMENTAL
Intervention: Multidisciplinary education programme (MEP)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Multidisciplinary education programme (MEP) followed by individual consultations
Number of subjects: 12
Study: 19716483

Group type: EXPERIMENTAL
Intervention: Tapered single‐cone technique (SC) in ProTaper (subgroup A1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Lateral condensation (LC) in ProTaper (subgroup A2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Warm vertical compaction (WVC) in ProTaper (subgroup A3)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tapered single‐cone technique (SC) in Mtwo (subgroup B1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Lateral condensation (LC) in Mtwo (subgroup B2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Warm vertical compaction (WVC) in Mtwo (subgroup B3)
Number of subjects: 80
Study: 16442873

Group type: EXPERIMENTAL
Intervention: Intervention school (Phase 1)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Intervention school (Phase 2)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control school (Phase 2)
Number of subjects: 2
Study: 15263100

Group type: EXPERIMENTAL
Intervention: Cessation of creatine supplementation with reduced-volume training (33% lower volume)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (no creatine supplementation)
Number of subjects: 8
Study: 11745278

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg daily
Number of subjects: 1021

Group type: COMPARATOR
Intervention: Tamoxifen 20 mg daily
Number of subjects: 1021
Study: 9052812

Group type: COMPARATOR
Intervention: 0 microg CNTF/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 15 microg CNTF/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 30 microg CNTF/kg
Number of subjects: 18
Study: 8109937

Group type: EXPERIMENTAL
Intervention: Teicoplanin (T) systemic prophylaxis - 800 mg in 100 ml saline as a 5-min infusion 2.5 h before surgery
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Teicoplanin (T) regional prophylaxis - 400 mg in 100 ml saline as a 5-min infusion immediately after tourniquet inflation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (systemic prophylaxis)
Number of subjects: 24
Study: 3518641

Group type: EXPERIMENTAL
Intervention: ORS60‐Gly110
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: ORS60‐Gly60
Number of subjects: 3

Group type: COMPARATOR
Intervention: ORS60
Number of subjects: 3
Study: 30014828

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 248

Group type: COMPARATOR
Intervention: Azithromycin
Number of subjects: 248

Group type: COMPARATOR
Intervention: Cotrimoxazole
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study: 26438637

Group type: EXPERIMENTAL
Intervention: Comprehensive Autism Program (CAP)
Number of subjects: 302

Group type: COMPARATOR
Intervention: business as usual programs
Number of subjects: 302
Study: 25070100

Group type: EXPERIMENTAL
Intervention: Rifampin 600 mg once daily for 6 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketoconazole 200 mg once daily for 7 days
Number of subjects: 0
Study: 21745832

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 120

Group type: COMPARATOR
Intervention: Gabapentin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 20210262

Group type: EXPERIMENTAL
Intervention: Health promotion intervention at worksites
Number of subjects: 341

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 341
Study: 18710624

Group type: EXPERIMENTAL
Intervention: Protective Ventilation (PV) group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional Ventilation (CV) group
Number of subjects: 40
Study: 15867643

Group type: EXPERIMENTAL
Intervention: 0.9% saline spray
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 3.0% saline spray
Number of subjects: 8
Study: 12532101

Group type: EXPERIMENTAL
Intervention: Omalizumab (at least 0.016 mg/kg/IgE [IU/mL], administered subcutaneously every 4 weeks)
Number of subjects: 1405

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1405
Study: 9895077

Group type: EXPERIMENTAL
Intervention: Morphine hydrochloride 0.01% administered via IV regional anesthesia (IVRA)
Number of subjects: 12
Study: 8892538

Group type: EXPERIMENTAL
Intervention: Slosson Oral Reading Test‐Revised
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Woodcock Reading Mastery Test‐Revised
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Wide Range Achievement Test‐Revised
Number of subjects: 123
Study: 1705685

Group type: EXPERIMENTAL
Intervention: Patients participating in self-care through nurse-patient interaction in addition to usual care (Experimental group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 40
Study: 6660205

Group type: EXPERIMENTAL
Intervention: Acupuncture on the normal side and rehabilitation (flection-extension exercise and massage on the affected joint)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture on the affected part of the affected side with rehabilitation on the affected part of the affected side
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture and rehabilitation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture on the normal side and rehabilitation on the affected part of the affected side
Number of subjects: 0
Study: 31802525

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tramadol
Number of subjects: 60
Study: 30853645

Group type: EXPERIMENTAL
Intervention: Anise oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28924371

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 72

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 72
Study: 26743526

Group type: EXPERIMENTAL
Intervention: 200 μg selenium supplements (n=30)
Number of subjects: 60
Study: 25140995

Group type: EXPERIMENTAL
Intervention: Methimazole treatment (30 mg daily for at least 1 month, followed by titration)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Methimazole treatment with L-thyroxine (30 mg daily for at least 1 month, followed by titration with L-thyroxine)
Number of subjects: 145
Study: 21809168

Group type: EXPERIMENTAL
Intervention: Aripiprazole (10-30 mg/day)
Number of subjects: 374

Group type: COMPARATOR
Intervention: RLAI (25-50 mg i.m. every 2 weeks)
Number of subjects: 374
Study: 19220543

Group type: EXPERIMENTAL
Intervention: Lactobacilli
Number of subjects: 359

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 359
Study: 17615501

Group type: EXPERIMENTAL
Intervention: HFA-BDP
Number of subjects: 77

Group type: COMPARATOR
Intervention: FP
Number of subjects: 77
Study: 14744821

Group type: EXPERIMENTAL
Intervention: Hands and knees position and pelvic rocking exercises from 37 weeks' gestation until the onset of labour
Number of subjects: 2547

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 2547

Group type: EXPERIMENTAL
Intervention: Hands and knees position and pelvic rocking exercises
Number of subjects: 2547
Study: 12616822

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 150 mg kg‐1 bolus followed by continuous infusion of 12 mg kg‐1 h‐1
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo (5% dextrose)
Number of subjects: 93
Study: 9836566

Group type: EXPERIMENTAL
Intervention: Streamtest cup
Number of subjects: 50

Group type: COMPARATOR
Intervention: Formal in-office uroflow study
Number of subjects: 50
Study: 7934757

Group type: EXPERIMENTAL
Intervention: Physically active commuting to work (PACW) 1 h daily for 10 weeks
Number of subjects: 68
Study: 2738277

Group type: EXPERIMENTAL
Intervention: Educational program for spouses of Alzheimer's patients
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 40
Study: 31111439

Group type: EXPERIMENTAL
Intervention: Aloe vera mouthwash
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Tea tree oil mouthwash
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 152
Study: 31666039

Group type: EXPERIMENTAL
Intervention: Vaccine reminder and tracker bracelets (two types of silicone bracelets)
Number of subjects: 1446

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1446
Study: 27794485

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 24